Your Health, We Care
Odevixibat is indicated for the treatment of pruritus in patients with PFIC aged 3 months and older.
Use RestrictionOdevixibat may be ineffective in a subgroup of patients with PFIC type 2 who have specific ABCB11 variants resulting in non-functional or complete absence of the bile salt export pump protein.
Odevixibat is indicated for the treatment of cholestatic pruritus in patients with ALGS aged 12 months and older.
FDA，2025.03
It is indicated for the treatment of cholestatic pruritus in patients aged 3 months and older with progressive familial intrahepatic cholestasis (PFIC) and patients aged 12 months ···【more】
Article source：Lucius LaosRelease date：2026-01-05Recommended：0
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
